endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB with regimens containing bedaquiline or delamanid

Principal investigator

Helena Huerga
Purpose of study
Purpose of study

To describe patient outcomes and assess factors associated with unfavorable outcomes (treatment failure, lost to follow-up and death). To estimate the frequency of adverse events of clinical significance.

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline


  • Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
    Hewison, Catherine "–" Oxford University Press (OUP) "(2022)"
  • Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
    Franke, Molly F. "–" American Thoracic Society "(2021)"
Previous study
Next study